Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet

Topics

Physics

Optics

Medicine

Epidemiology

Immunology

Show all topics

DOI

10.1016/s0140-6736(07)60777-6